25T7-NBOMe: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
{{Short description|A synthetic psychedelic compound}}
{{DISPLAYTITLE:25T7-NBOMe}}
{{Drugbox
| verifiedrevid = 477318123
| IUPAC_name = 2-(4-(2-(4-isopropylthio-2,5-dimethoxyphenyl)ethyl)phenyl)-N-(2-methoxybenzyl)ethanamine
| image = 25T7-NBOMe_structure.png
}}


'''25T7-NBOMe''' is a synthetic psychedelic compound belonging to the [[NBOMe series]]. It is a derivative of the phenethylamine [[2C-T-7]], and is known for its potent [[hallucinogenic]] effects.  
== Overview ==
'''25T7-NBOMe''' is a synthetic psychedelic compound belonging to the [[NBOMe]] series. It is a derivative of the phenethylamine [[2C-T-7]], modified by the addition of a 2-methoxybenzyl group to the nitrogen atom. This modification significantly increases the compound's potency as a [[serotonin receptor]] agonist, particularly at the [[5-HT2A receptor]].


==Chemical structure and properties==
== Chemical Structure ==
25T7-NBOMe is chemically classified as a [[phenethylamine]] and a [[substituted amphetamine]]. Its structure includes a 2,5-dimethoxyphenethylamine core with an isopropylthio group at the 4-position and a 2-methoxybenzyl group attached to the nitrogen atom. This modification is responsible for its high affinity for the [[serotonin receptor|5-HT2A receptor]], which is thought to mediate its psychedelic effects.
[[File:25T7-NBOMe_structure.png|thumb|right|Chemical structure of 25T7-NBOMe]]
The chemical structure of 25T7-NBOMe is characterized by the presence of a 2-methoxybenzyl group attached to the nitrogen of the phenethylamine backbone. This structural modification is responsible for its high affinity for the 5-HT2A receptor, which is the primary target for its psychedelic effects.


==Pharmacology==
== Pharmacology ==
25T7-NBOMe acts primarily as a potent agonist of the [[5-HT2A receptor]], similar to other compounds in the NBOMe series. This receptor is a subtype of the [[serotonin receptor]] and is heavily involved in the modulation of mood, perception, and cognition. The activation of this receptor by 25T7-NBOMe is believed to be responsible for its psychedelic effects, which can include altered visual and auditory perceptions, changes in thought patterns, and an altered sense of time.
25T7-NBOMe acts as a potent agonist at the [[5-HT2A receptor]], which is a subtype of the [[serotonin receptor]] family. Activation of this receptor is known to produce psychedelic effects, including alterations in perception, mood, and cognition. The compound's high potency means that it is active at very low doses, which can increase the risk of overdose and adverse effects.


==Effects==
== Effects ==
The effects of 25T7-NBOMe are similar to those of other psychedelics, such as [[LSD]] and [[psilocybin]]. Users report intense visual hallucinations, euphoria, and a sense of connection with the universe. However, the compound is also associated with adverse effects, including anxiety, paranoia, and, in some cases, dangerous physiological reactions such as [[tachycardia]] and [[hypertension]].
The effects of 25T7-NBOMe are similar to those of other psychedelics, such as [[LSD]] and [[psilocybin]]. Users may experience visual and auditory hallucinations, changes in thought patterns, and an altered sense of time. However, due to its high potency, the effects can be unpredictable and may include severe anxiety, paranoia, and other negative psychological reactions.


==Legal status==
== Risks and Safety ==
The legal status of 25T7-NBOMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is important for researchers and users to be aware of the legal implications of possessing or distributing this compound.
Due to its potency and the potential for severe adverse effects, 25T7-NBOMe is considered a dangerous substance. Overdose can lead to serious health complications, including [[seizures]], [[hypertension]], and [[tachycardia]]. There have been reports of fatalities associated with its use, often due to misidentification or improper dosing.


==Safety and toxicity==
== Legal Status ==
The safety profile of 25T7-NBOMe is not well-established, and there have been reports of severe adverse reactions and fatalities associated with its use. The compound's potency and the variability in individual responses make it particularly risky. Users are advised to exercise caution and to be aware of the potential for overdose.
The legal status of 25T7-NBOMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Users should be aware of the legal implications of possessing or distributing this compound.


==Related pages==
== Related Compounds ==
* [[NBOMe series]]
* [[2C-T-7]]
* [[2C-T-7]]
* [[NBOMe]]
* [[25I-NBOMe]]
* [[25C-NBOMe]]
== Related Pages ==
* [[Psychedelic drug]]
* [[Psychedelic drug]]
* [[Serotonin receptor]]
* [[Serotonin receptor]]
 
* [[Hallucinogen]]
==Gallery==
<gallery>
File:25T7-NBOMe_structure.png|Chemical structure of 25T7-NBOMe
</gallery>


[[Category:Psychedelic phenethylamines]]
[[Category:Psychedelic phenethylamines]]
[[Category:Serotonin receptor agonists]]
[[Category:Serotonin receptor agonists]]

Latest revision as of 11:43, 15 February 2025


Overview[edit]

25T7-NBOMe is a synthetic psychedelic compound belonging to the NBOMe series. It is a derivative of the phenethylamine 2C-T-7, modified by the addition of a 2-methoxybenzyl group to the nitrogen atom. This modification significantly increases the compound's potency as a serotonin receptor agonist, particularly at the 5-HT2A receptor.

Chemical Structure[edit]

Chemical structure of 25T7-NBOMe

The chemical structure of 25T7-NBOMe is characterized by the presence of a 2-methoxybenzyl group attached to the nitrogen of the phenethylamine backbone. This structural modification is responsible for its high affinity for the 5-HT2A receptor, which is the primary target for its psychedelic effects.

Pharmacology[edit]

25T7-NBOMe acts as a potent agonist at the 5-HT2A receptor, which is a subtype of the serotonin receptor family. Activation of this receptor is known to produce psychedelic effects, including alterations in perception, mood, and cognition. The compound's high potency means that it is active at very low doses, which can increase the risk of overdose and adverse effects.

Effects[edit]

The effects of 25T7-NBOMe are similar to those of other psychedelics, such as LSD and psilocybin. Users may experience visual and auditory hallucinations, changes in thought patterns, and an altered sense of time. However, due to its high potency, the effects can be unpredictable and may include severe anxiety, paranoia, and other negative psychological reactions.

Risks and Safety[edit]

Due to its potency and the potential for severe adverse effects, 25T7-NBOMe is considered a dangerous substance. Overdose can lead to serious health complications, including seizures, hypertension, and tachycardia. There have been reports of fatalities associated with its use, often due to misidentification or improper dosing.

Legal Status[edit]

The legal status of 25T7-NBOMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Users should be aware of the legal implications of possessing or distributing this compound.

Related Compounds[edit]

Related Pages[edit]